State Street Corp 89bio, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in 89bio, Inc. stock. As of the latest transaction made, State Street Corp holds 5,543,588 shares of ETNB stock, worth $41.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,543,588
Previous 5,399,358
2.67%
Holding current value
$41.7 Million
Previous $60.3 Million
6.99%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ETNB
# of Institutions
164Shares Held
89.1MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$94.8 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$55.5 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$49.9 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$47.4 Million3.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$35.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $350M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...